Get the Stockscreener App
98.49
2.65%
2.54
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $98.49, with a volume of 1.18M.
It is up +2.65% in the last 24 hours and down -5.14% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$95.95
Open:
$96.59
24h Volume:
1.18M
Relative Volume:
0.89
Market Cap:
$11.01B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
41.91
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+0.94%
1M Performance:
-5.14%
6M Performance:
+14.92%
1Y Performance:
-9.86%
1-Day Range:
$95.82
$98.57
1-Week Range:
$91.13
$99.20
52-Week Range:
$81.36
$120.39
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
98.49 | 10.73B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report? - Yahoo Finance
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView
RVTY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revvity at TD Cowen: Strategic Growth and Margin Expansion - Investing.com
Here's Why Keeping Revvity Stock in Your Portfolio Makes Sense at This Time - Bitget
Revvity, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Citigroup Inc. Has $6.58 Million Stock Position in Revvity Inc. $RVTY - MarketBeat
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity at Raymond James Conference: Strategic Growth and AI Opportunities - Investing.com South Africa
Transcript : Revvity, Inc. Presents at 47th Annual Raymond James Institutional Investor Conference, Mar-02-2026 07 - marketscreener.com
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
Mitsubishi UFJ Asset Management Co. Ltd. Acquires 16,632 Shares of Revvity Inc. $RVTY - MarketBeat
RVTYRevvity Inc Latest Stock News & Market Updates - Stock Titan
RVTY SEC FilingsRevvity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Revvity Inc Stock Price ($RVTY.RTH), Quote & News - eToro
Revvity (NYSE:RVTY) Rating Increased to Buy at Wall Street Zen - MarketBeat
Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor Intelligence - GlobeNewswire Inc.
Primecap Management Co. CA Reduces Stake in Revvity Inc. $RVTY - MarketBeat
JPMorgan Chase & Co. Has $44.82 Million Position in Revvity Inc. $RVTY - MarketBeat
Revvity’s AI Push Brings Innovation Potential but Heightened Operational, Legal, and Reputational Risks - The Globe and Mail
Avoiding Lag: Real-Time Signals in (RVTY) Movement - Stock Traders Daily
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity (RVTY) insider exercises options then sells 1,862 common shares - Stock Titan
Zacks Research Brokers Lift Earnings Estimates for Revvity - MarketBeat
Insider Sell: Michelle Mcmurry-heath Sells Shares of Revvity Inc (RVTY) - GuruFocus
Revvity (RVTY) director sells 600 shares in open-market trade - Stock Titan
Zacks Research Estimates Revvity's Q1 Earnings (NYSE:RVTY) - MarketBeat
Decoding Revvity Inc (RVTY): A Strategic SWOT Insight - GuruFocus
How Investors May Respond To Revvity (RVTY) Strong Q4 Beat And Upbeat 2026 Outlook - Yahoo Finance
Revvity : Annual Report for Fiscal Year Ending 12/28, 2025 (Form 10-K) - marketscreener.com
[144] REVVITY, INC. SEC Filing - Stock Titan
Revvity Inc. $RVTY Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
Bond Watch: Is Revvity Inc showing insider buyingJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - baoquankhu1.vn
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - The Globe and Mail
Do Wall Street Analysts Like Revvity Stock? - Barchart.com
Vanguard Group Inc. Lowers Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Aberdeen Group plc Cuts Stake in Revvity Inc. $RVTY - MarketBeat
Can Revvity Inc. stock hit record highs againExit Point & Risk Controlled Daily Plans - mfd.ru
King Luther Capital Management Corp Has $10.45 Million Stake in Revvity Inc. $RVTY - MarketBeat
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Revvity tackles hidden TB threat with early testing strategy - Traders Union
Bretton Fund exits UNP and RVTY - MSN
Revvity (RVTY) officer surrenders 1,733 shares to cover tax - Stock Titan
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of “Hold” by Analysts - Defense World
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - MSN
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - MSN
How To YieldBoost Revvity To 22.5% Using Options - Nasdaq
First National Bank of Omaha Buys New Position in Revvity Inc. $RVTY - MarketBeat
Revvity to Present at Upcoming Investor Conferences - pharmiweb.com
A major biomanufacturer is cutting over 100 jobs in Mass. - MSN
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):